143 related articles for article (PubMed ID: 23206847)
1. Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia.
Vago L; Toffalori C; Ciceri F; Fleischhauer K
Semin Oncol; 2012 Dec; 39(6):707-15. PubMed ID: 23206847
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
3. Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.
Hirosawa T; Torikai H; Yanagisawa M; Kamei M; Imahashi N; Demachi-Okamura A; Tanimoto M; Shiraishi K; Ito M; Miyamura K; Shibata K; Kikkawa F; Morishima Y; Takahashi T; Emi N; Kuzushima K; Akatsuka Y
Cancer Sci; 2011 Jul; 102(7):1281-6. PubMed ID: 21466613
[TBL] [Abstract][Full Text] [Related]
4. Genomic polymorphism and allogeneic hematopoietic transplantation outcome.
Mullighan CG; Petersdorf EW
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):19-27. PubMed ID: 16399580
[TBL] [Abstract][Full Text] [Related]
5. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.
Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Moretta A; Sivori S
J Leukoc Biol; 2011 Oct; 90(4):661-7. PubMed ID: 21791599
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation.
Ruggeri L; Mancusi A; Burchielli E; Aversa F; Martelli MF; Velardi A
Curr Opin Oncol; 2007 Mar; 19(2):142-7. PubMed ID: 17272987
[TBL] [Abstract][Full Text] [Related]
7. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
Ruggeri L; Capanni M; Mancusi A; Urbani E; Perruccio K; Burchielli E; Tosti A; Topini F; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2004; 33(3):216-21. PubMed ID: 15528134
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation.
Tamaki H; Fujioka T; Ikegame K; Yoshihara S; Kaida K; Taniguchi K; Kato R; Tokugawa T; Nakata J; Inoue T; Yano A; Eguchi R; Okada M; Maruya E; Saji H; Ogawa H
Eur J Haematol; 2012 Dec; 89(6):497-500. PubMed ID: 23033942
[TBL] [Abstract][Full Text] [Related]
9. Loss of mismatched HLA in leukemia after stem-cell transplantation.
Vago L; Perna SK; Zanussi M; Mazzi B; Barlassina C; Stanghellini MT; Perrelli NF; Cosentino C; Torri F; Angius A; Forno B; Casucci M; Bernardi M; Peccatori J; Corti C; Bondanza A; Ferrari M; Rossini S; Roncarolo MG; Bordignon C; Bonini C; Ciceri F; Fleischhauer K
N Engl J Med; 2009 Jul; 361(5):478-88. PubMed ID: 19641204
[TBL] [Abstract][Full Text] [Related]
10. At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.
Norell H; Moretta A; Silva-Santos B; Moretta L
J Leukoc Biol; 2013 Dec; 94(6):1123-39. PubMed ID: 24108703
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
12. Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
Sasazuki T; Inoko H; Morishima S; Morishima Y
Adv Immunol; 2016; 129():175-249. PubMed ID: 26791860
[TBL] [Abstract][Full Text] [Related]
13. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
Jones SC; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
[TBL] [Abstract][Full Text] [Related]
14. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
Verheyden S; Schots R; Duquet W; Demanet C
Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
Front Immunol; 2020; 11():147. PubMed ID: 32158444
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.
Aversa F; Martelli MF; Velardi A
Semin Oncol; 2012 Dec; 39(6):643-52. PubMed ID: 23206841
[TBL] [Abstract][Full Text] [Related]
17. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
18. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
Koh LP; Rizzieri DA; Chao NJ
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
[TBL] [Abstract][Full Text] [Related]
20. Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?
Hosseini E; Schwarer AP; Ghasemzadeh M
Exp Hematol; 2015 Mar; 43(3):149-57. PubMed ID: 25434712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
